Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Aveanna Healthcare Holdings ( (AVAH) ) has provided an update.
Aveanna Healthcare Holdings announced its third-quarter financial results for 2025, showing a significant improvement with a 22.2% increase in revenue to $621.9 million and a net income of $14.1 million compared to a net loss in the previous year. The company also revised its full-year 2025 revenue and Adjusted EBITDA guidance upwards, reflecting sustained business momentum and successful strategic transformations, including the integration of Thrive Skilled Pediatric Care.
The most recent analyst rating on (AVAH) stock is a Buy with a $12.50 price target. To see the full list of analyst forecasts on Aveanna Healthcare Holdings stock, see the AVAH Stock Forecast page.
Spark’s Take on AVAH Stock
According to Spark, TipRanks’ AI Analyst, AVAH is a Neutral.
Aveanna Healthcare Holdings’ overall stock score is driven by strong earnings call performance and positive technical indicators. However, the high P/E ratio and significant financial challenges, including high leverage and negative equity, weigh heavily on the score. The absence of a dividend yield and potential regulatory risks further impact the valuation negatively.
To see Spark’s full report on AVAH stock, click here.
More about Aveanna Healthcare Holdings
Aveanna Healthcare Holdings Inc. is a leading, diversified home care platform that focuses on providing care to medically complex, high-cost patient populations. The company operates with a national footprint, delivering cost-effective and high-quality home care services, which are of significant value to their payor and government partners.
Average Trading Volume: 1,719,077
Technical Sentiment Signal: Buy
Current Market Cap: $1.94B
Find detailed analytics on AVAH stock on TipRanks’ Stock Analysis page.